NCT02725489 2021-01-27Pilot Study of Durvalumab and Vigil in Advanced Women's CancersMary Crowley Medical Research CenterPhase 2 Completed13 enrolled
NCT00002475 2013-07-10Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced CancerNational Cancer Institute (NCI)Phase 2 Completed40 enrolled